Moneycontrol Be a Pro
Get App
Last Updated : Jul 10, 2013 10:50 AM IST | Source: CNBC-TV18

Houseviews: Buy JP Associates, Sun Pharma, Glenmark

Here's how brokerages are recommending trading JP Associates, Sun Pharma, Idea Cellular and Glenmark.


Here's how brokerages are recommending trading the following stocks:


JP Associates
Brokerage:
Bank of America Merrill Lynch
Rating: BUY
Target: Rs 99
Rationale: The company turned free cash flow positive, in-line with expectations, but it was a positive surprise for markets.


Sun Pharma
Brokerage:
Macquarie
Rating: OUTPERFORM
Target: Rs 1250
Rationale: Hikma yesterday increased its 2013 sales forecast citing strong sales of Doxycycline as one of the key drivers. URL, which was acquired by Sun, also benefits as they market the generic version of Doxycyclene.


Glenmark
Brokerage:
Credit Suisse
Rating: OUTPERFORM
Target: Rs 680
Rationale: The brokerage is positive on the company’s improved balance sheets and quality of filings and have raised FY14 earnings estimates by 15%.

Idea Cellular
Bropkerage:
Jefferies
Rating: DOWNGRADE
Target: Rs 120
Rationale: Idea has had a strong run given good execution in the wireless business and a lack of credible alternatives as Bharti continues to face challenges, especially in Africa.



Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jul 10, 2013 08:58 am
Loading...
Sections
Follow us on
Available On